Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of eczema, known as atopic dermatitis, is characterized by persistent itching ...

NIH researchers define diagnostic criteria for topical steroid withdrawal (TSW), distinguishing it from eczema.

Topical treatment options for asteatotic eczema may include: In some cases, oral antihistamines can help prevent the itching associated with an asteatotic eczema flare-up. For more severe ...

What begins as a standard treatment protocol often evolves into an unexpected battle with topical steroid withdrawal, challenging conventional approaches to eczema care. Many individuals who rely ...

The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...

Phase 3 trial results show roflumilast cream 0.05% to be a safe and effective treatment for children with atopic dermatitis.

Despite multiple treatments for eczema and pityriasis alba, a child’s skin condition worsened until a biopsy revealed mycosis ...

Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in Pediatric Dermatology.

As TSW and eczema have similar symptoms ... People who have stopped topical steroid treatment and meet the criteria may be diagnosed by practitioners as having TSW. The researchers suggest ...